These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 11155746)
1. Titration study of MUSE (Medicated Urethral System for Erection) in erectile dysfunction. Chiang HS; Wen TC; Liang JF J Formos Med Assoc; 2000 Dec; 99(12):926-30. PubMed ID: 11155746 [TBL] [Abstract][Full Text] [Related]
2. Transurethral alprostadil with MUSE (medicated urethral system for erection) vs intracavernous alprostadil--a comparative study in 103 patients with erectile dysfunction. Porst H Int J Impot Res; 1997 Dec; 9(4):187-92. PubMed ID: 9442415 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of transurethral application of alprostadil for erectile dysfunction in Indonesians. Pangkahila WI Asian J Androl; 2000 Sep; 2(3):233-6. PubMed ID: 11225984 [TBL] [Abstract][Full Text] [Related]
4. [Transurethral alprostadil administration with MUSE ("Medicated Urethral System for Erection"). Current overview and personal experiences]. Porst H Urologe A; 1998 Jul; 37(4):410-6. PubMed ID: 9738294 [TBL] [Abstract][Full Text] [Related]
5. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)]. Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074 [TBL] [Abstract][Full Text] [Related]
6. Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting. Fulgham PF; Cochran JS; Denman JL; Feagins BA; Gross MB; Kadesky KT; Kadesky MC; Clark AR; Roehrborn CG J Urol; 1998 Dec; 160(6 Pt 1):2041-6. PubMed ID: 9817319 [TBL] [Abstract][Full Text] [Related]
7. Intraurethral alprostadil for treatment of erectile dysfunction in patients with spinal cord injury. Bodner DR; Haas CA; Krueger B; Seftel AD Urology; 1999 Jan; 53(1):199-202. PubMed ID: 9886612 [TBL] [Abstract][Full Text] [Related]
8. The lowest effective dose of prostaglandin E1 as treatment for erectile dysfunction. Chen J; Godschalk M; Katz PG; Mulligan T J Urol; 1995 Jan; 153(1):80-1. PubMed ID: 7966797 [TBL] [Abstract][Full Text] [Related]
10. Relation between intracavernosal dose of prostaglandin Pge 1 and mean duration of erection in men with different underlying causes of erectile dysfunction. Bratus D; Hlebic G; Hajdinjak T Croat Med J; 2007 Feb; 48(1):76-80. PubMed ID: 17309142 [TBL] [Abstract][Full Text] [Related]
11. Combination therapy: medicated urethral system for erection enhances sexual satisfaction in sildenafil citrate failure following nerve-sparing radical prostatectomy. Raina R; Nandipati KC; Agarwal A; Mansour D; Kaelber DC; Zippe CD J Androl; 2005; 26(6):757-60. PubMed ID: 16291971 [TBL] [Abstract][Full Text] [Related]
12. Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group. Padma-Nathan H; Hellstrom WJ; Kaiser FE; Labasky RF; Lue TF; Nolten WE; Norwood PC; Peterson CA; Shabsigh R; Tam PY; Place VA; Gesundheit N N Engl J Med; 1997 Jan; 336(1):1-7. PubMed ID: 8970933 [TBL] [Abstract][Full Text] [Related]
13. Transurethral alprostadil with MUSE (medicated urethral system for erection) vs intracavernous alprostadil--a comparative study in 103 patients with erectile dysfunction. Lewis RW Int J Impot Res; 1998 Mar; 10(1):61-2. PubMed ID: 9542692 [No Abstract] [Full Text] [Related]
14. Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy. Nehra A; Blute ML; Barrett DM; Moreland RB Int J Impot Res; 2002 Feb; 14 Suppl 1():S38-42. PubMed ID: 11850734 [TBL] [Abstract][Full Text] [Related]
15. Clinical experience with intraurethral alprostadil (MUSE) in the treatment of men with erectile dysfunction. A retrospective study. Medicated urethral system for erection. Guay AT; Perez JB; Velásquez E; Newton RA; Jacobson JP Eur Urol; 2000 Dec; 38(6):671-6. PubMed ID: 11111182 [TBL] [Abstract][Full Text] [Related]
16. Multicenter study of the treatment of erectile dysfunction with transurethral alprostadil (MUSE) in Korea. Kim SC; Ahn TY; Choi HK; Choi NG; Chung TG; Chung WS; Hwang TK; Hyun JS; Jung GW; Kim CI; Kim JJ; Kim SW; Lee CH; Lee KS; Lee WH; Min KS; Moon KH; Paic JS; Park KS; Park NC; Park YK; Seo JK; Seo KK; Shin JS; Yoon YR; Lee WC Int J Impot Res; 2000 Apr; 12(2):97-101. PubMed ID: 11052635 [TBL] [Abstract][Full Text] [Related]
18. Long-term efficacy and compliance of MUSE for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis. Raina R; Agarwal A; Zaramo CE; Ausmundson S; Mansour D; Zippe CD Int J Impot Res; 2005; 17(1):86-90. PubMed ID: 15526008 [TBL] [Abstract][Full Text] [Related]
19. Optimizing the therapeutic approach of transurethral alprostadil. Ekman P; Sjögren L; Englund G; Persson BE BJU Int; 2000 Jul; 86(1):68-74. PubMed ID: 10886086 [TBL] [Abstract][Full Text] [Related]
20. The early use of transurethral alprostadil after radical prostatectomy potentially facilitates an earlier return of erectile function and successful sexual activity. Raina R; Pahlajani G; Agarwal A; Zippe CD BJU Int; 2007 Dec; 100(6):1317-21. PubMed ID: 17850385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]